MS 10 — Supporting women’s menopausal health — webinar

As women seek new solutions for menopause, a new natural blend from Famenity, MS-10®, provides strong clinical support.

October 16, 2023

1 Hr View
Adobe Stock

Date: Oct 16, 2023

Duration: 1 Hr

At a Glance

  • Hear the specifics on this new proprietary botanical ingredient and how it is meeting new market demands
  • Learn about the various human clinical trials supporting MS-10’s efficacy
  • Gain understanding of its regulatory approvals and allowable label claims

Women are looking for new solutions, especially botanicals, to address the symptoms of menopause. But at the same time, science is particularly important in this category, so botanical ingredients with strong clinical substantiation are increasingly important.

Famenity’s MS-10® fits the bill. It is a proprietary blend of natural botanical dietary ingredients extracted from thistle and thyme. In a series of published, peer-reviewed in vitro, in vivo and double-blind randomized placebo-controlled human clinical studies, researchers found that MS-10® exerted significant improvement in alleviating menopausal symptoms, regulating estrogen receptor activity, and improving bone health blood serum markers in menopausal women. 

Join us for this overview of MS-10 with regulatory expert Chanel Kaminis, compliance director for the Bent Creek Institute, who is representing Famenity, the makers of MS-10. Ms. Kaminis will provide an outline of the science and safety data on this proprietary new ingredient. 

Moderator:

Karen Raterman
Associate Director, Content Marketing, Natural Products Insider 

Speaker:

Chanel Kaminis
Compliance Director, the Bent Creek Institute

As compliance director for the Bent Creek Institute (BCI), Ms. Kaminis maintains up-to-date awareness of the U.S. regulatory environment pertaining to dietary supplements, foods and cosmetics. At BCI she specializes in consulting services for the preparation and submission of New Dietary Ingredient Notifications to the U.S. FDA. To-date she has filed seven successful NDIN’s on Famenity’s behalf for a wide range of their dietary supplement products. Most recently she secured an NDIN with FDA for MS-10. 

Read more about:

Webinars
Subscribe for the latest consumer trends, trade news, nutrition science and regulatory updates in the supplement industry!
Join 37,000+ members. Yes, it's completely free.

You May Also Like